RBC Capital raised the firm’s price target on Pacs Group to $32 from $30 and keeps an Outperform rating on the shares. The company’s Q1 results were “strong”, and its FY24 revenue and adjusted EBITDA guidance came in ahead of consensus, supported by strong occupancy and solid reimbursement, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACS: